Waneta Tuttle

Waneta C.
Tuttle was the founder of DNA Electronics, Inc. (founded 2007) serving as Director; Exagen, Inc. (founded 2002) serving as Interim Chief Executive Officer from 2002 to 2010; PhDx Systems, Inc. (founded 1994) serving as Chairman from 2009 to 2011; and Tramway Ventures LLC (founded 2017) serving as Managing Partner since 2017.
Current jobs include Director at Agilvax, Inc., Tramway Technologies LLC, Armonica Technologies, Inc., BennuBio, Inc., Circular Genomics, Inc., Vitazi.
AI, Inc., and WaveFront Dynamics, Inc. since 2020; President & Director at Tramway Life Sciences LLC; Advisor at Tullis Health Investors, Inc.; and Member at The University of New Mexico.
Former jobs include Chief Executive Officer at Indigo Medical, Inc.; Director at MGI PHARMA, Inc. from 2004 to 2008; Director at Health Care Service Corp.; Director at The National Center for Genome Resources from 1995 to 2004; Member at The Charles Stark Draper Laboratory, Inc. from 1994 to 2014; and Chief Operating Officer & Vice President at Lovelace Medical Group.
Education includes undergraduate, graduate, and MBAistration degrees from The University of New Mexico.